safety and efficacy of ribociclib and letrozole in advanced breast cancer – the monaleesa-2 trial
Published 7 years ago • 2.7K plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
1:19
monaleesa-2: improved os seen in hr advanced breast cancer treated with ribociclib letrozole
-
1:29
monaleesa-2: ribociclib letrozole in pts with de novo metastatic disease and late recurrence
-
1:40
early ribecca results: ribociclib with letrozole for metastatic breast cancer
-
1:21
qol in monaleesa-2, 3, and 7
-
1:39
frontline endocrine therapies and ribociclib in early stage hr her2- breast cancer
-
7:14
ribociclib for hr advanced breast cancer
-
7:21
fda approval of ribociclib for metastatic breast cancer
-
9:39
esmo 2016: press brief on the monaleesa-2 clinical trial on breast cancer
-
3:11
a correlative analysis of coralleen: preoperative ribociclib letrozole vs chemo in hr /her2- bc
-
1:11
results of trial of ribociclib with everolimus and exemestane in breast cancer
-
13:53
gs2-01: "overall survival subgroup analysis by metastatic site from the phase3 monaleesa-2..."
-
2:26
updated results of the monaleesa-2 trial in hr /her2- breast cancer
-
0:36
maintenance w/ et ribociclib after 1l chemotherapy in hr /her2- metastatic breast cancer
-
13:54
overall survival results from monaleesa-2: endocrine therapy and ribociclib in hr positive and h...
-
1:26
ribecca: ribociclib, a cdk4/6 inhibitor in er breast cancer
-
10:15
monaleesa-3 os results: fulvestrant/ribociclib in postmenopausal hr /her2- advanced breast cancer
-
1:48
natalee and monarche: ribociclib and abemaciclib in hr /her2- breast cancer
-
3:38
efficacy and quality of life outcomes with ribociclib plus letrozole vs letrozole alone for mbc
-
2:40
dr. hortobagyi on monaleesa-2 trial results in breast cancer